NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/08/2024
Back to search
Official data from USPTO
OXYDRENALN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
10/08/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
07/03/2023
Registration date
10/08/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/08/2024
Last transaction
10/08/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/01/2023
First use in commerce
07/01/2023
Drawing code
4
Owner type
16
Owner location
Wantage, NJ, US
Examiner
REEVES, APRIL
Law office
N60
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Drenaln Labs LLC
Representatives
Courtney M. Alvarez CMA TRADEMARKS, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Amino acids for nutritional purposes; Dietary supplements; Nutritional supplements; Powdered nutritional supplement drink mix containing protein; all the forgoing not being for skin care or acne care.
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/01/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/25/2024
APET
ASSIGNED TO PETITION STAFF
07/24/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/29/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2024
DOCK
ASSIGNED TO EXAMINER
03/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2023
NWAP
NEW APPLICATION ENTERED
07/06/2023
Continuous trademark protection
Get notified about every new filing that threatens OXYDRENALN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.